573 related articles for article (PubMed ID: 28705716)
21. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients.
Mitsumoto-Kaseida F; Murata M; Takayama K; Toyoda K; Ogawa E; Furusyo N; Hayashi J
J Infect Chemother; 2020 Jan; 26(1):28-32. PubMed ID: 31279522
[TBL] [Abstract][Full Text] [Related]
23. Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
Coffin CS; Mulrooney-Cousins PM; Osiowy C; van der Meer F; Nishikawa S; Michalak TI; van Marle G; Gill MJ
J Clin Virol; 2014 Aug; 60(4):347-53. PubMed ID: 24881491
[TBL] [Abstract][Full Text] [Related]
24. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
[TBL] [Abstract][Full Text] [Related]
25. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
26. Are current screening protocols for chronic hepatitis B virus infection adequate?
Mortensen E; Kamali A; Schirmer PL; Lucero-Obusan C; Winston CA; Oda G; Winters MA; Durfee J; Martinello RA; Davey VJ; Holodniy M
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):159-67. PubMed ID: 27009896
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
Sondlane TH; Mawela L; Razwiedani LL; Selabe SG; Lebelo RL; Rakgole JN; Mphahlele MJ; Dochez C; De Schryver A; Burnett RJ
Vaccine; 2016 Jul; 34(33):3835-9. PubMed ID: 27265453
[TBL] [Abstract][Full Text] [Related]
28. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
[TBL] [Abstract][Full Text] [Related]
29. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
[TBL] [Abstract][Full Text] [Related]
30. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis.
Foaud H; Maklad S; Mahmoud F; El-Karaksy H
Infection; 2015 Jun; 43(3):307-14. PubMed ID: 25665956
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, risk factors, and molecular characterization of occult hepatitis B infection among anti-hepatitis B core antigen alone subjects.
Azarkar Z; Ziaee M; Ebrahimzadeh A; Sharifzadeh G; Javanmard D
J Med Virol; 2019 Apr; 91(4):615-622. PubMed ID: 30345529
[TBL] [Abstract][Full Text] [Related]
33. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
34. [Significance of hepatitis B core antibody as the only marker of hepatitis B infection].
Colomina-Rodríguez J; González-García D; Burgos-Teruel A; Fernández-Lorenz N; Guerrero-Espejo A
Enferm Infecc Microbiol Clin; 2005 Feb; 23(2):80-5. PubMed ID: 15743579
[TBL] [Abstract][Full Text] [Related]
35. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of occult hepatitis B cases in Greek blood donors.
Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
[TBL] [Abstract][Full Text] [Related]
37. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
38. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
[TBL] [Abstract][Full Text] [Related]
39. Occult hepatitis B infections among blood donors in Lao PDR.
Jutavijittum P; Andernach IE; Yousukh A; Samountry B; Samountry K; Thammavong T; Keokhamphue J; Toriyama K; Muller CP
Vox Sang; 2014 Jan; 106(1):31-7. PubMed ID: 23931585
[TBL] [Abstract][Full Text] [Related]
40. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
